How does KLYG's PS Ratio compare to its peers?

KLYG is expensive based on its Price-To-Sales Ratio (2.5x) compared to the peer average (1.1x).

How does KLYG's PS Ratio compare vs other companies in the US Medical Equipment Industry?

KLYG is good value based on its Price-To-Sales Ratio (2.5x) compared to the US Medical Equipment industry average (3.2x).

What is KLYG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate KLYG's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of KLYG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate KLYG's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

KLYG Stock Overview

A medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. More details

KLYG fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Risk Analysis

Earnings have declined by 8.8% per year over past 5 years

Does not have a meaningful market cap ($7M)

Shareholders have been diluted in the past year

Does not have meaningful revenue ($3M)

+ 1 more risk

My Notes

Capture your thoughts, links and company narrative

Kelyniam Global, Inc. Competitors

Predictive Oncology

NasdaqCM:POAI

US$4.6m

Nuwellis

NasdaqCM:NUWE

US$3.7m

Cutera

NasdaqGS:CUTR

US$7.3m

Scientific Industries

OTCPK:SCND

US$9.5m

Price History & Performance

Summary of share price highs, lows and changes for Kelyniam Global
Historical stock prices
Current Share Price	US$0.22
52 Week High	US$0.29
52 Week Low	US$0.042
Beta	-1.27
1 Month Change	6.38%
3 Month Change	71.85%
1 Year Change	257.44%
3 Year Change	120.97%
5 Year Change	112.76%
Change since IPO	-18.76%

Recent updates

Shareholder Returns

	KLYG	US Medical Equipment	US Market
7D	-2.9%	-1.5%	-2.4%
1Y	257.4%	10.0%	23.4%

Return vs Industry: KLYG exceeded the US Medical Equipment industry which returned 10.1% over the past year.

Return vs Market: KLYG exceeded the US Market which returned 23.3% over the past year.

Price Volatility

Is KLYG's price volatile compared to industry and market?
KLYG volatility
KLYG Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	7.6%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.8%
10% least volatile stocks in US Market	3.1%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine KLYG's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2005	n/a	Ross Bjella	www.kelyniam.com

Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial and maxilla-facial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors.

Kelyniam Global, Inc. Fundamentals Summary

How do Kelyniam Global's earnings and revenue compare to its market cap?
KLYG fundamental statistics
Market cap	US$6.80m
Earnings (TTM)	-US$218.47k
Revenue (TTM)	US$2.67m

2.5x

P/S Ratio

-31.1x

P/E Ratio

Is KLYG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KLYG income statement (TTM)
Revenue	US$2.67m
Cost of Revenue	US$636.28k
Gross Profit	US$2.04m
Other Expenses	US$2.25m
Earnings	-US$218.47k

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0072
Gross Margin	76.19%
Net Profit Margin	-8.18%
Debt/Equity Ratio	80.1%

How did KLYG perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 10:16
End of Day Share Price	2024/12/20 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kelyniam Global, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

Kelyniam Global OTCPK:KLYG Stock Report